Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa
Author(s)
Type
Journal Article
Date Issued
2010
Citation
PLoS One, 2010, 5, pp.e12873-
ISSN
1932-6203
Publisher
PUBLIC LIBRARY SCIENCE
Start Page
e12873
Journal / Book Title
PLoS One
Volume
5
Issue
9
Copyright Statement
© This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Description
24/01/13 meb. Open access paper, OK to pub.
Identifier
http://www.ncbi.nlm.nih.gov/pubmed/20877623
Subjects
AIDS Vaccines/*adverse effects/*immunology Adenoviridae/genetics/*immunology Adolescent Adult Antibodies, Viral/immunology Double-Blind Method Drug-Related Side Effects and Adverse Reactions Genetic Vectors/adverse effects/genetics/*immunology HIV Infections/*immunology/prevention & control/virology HIV-1/classification/genetics/immunology Humans Immunization, Secondary Male Middle Aged Vaccines, DNA/adverse effects/*immunology Young Adult gag Gene Products, Human Immunodeficiency Virus/adverse effects/genetics/immunology pol Gene Products, Human Immunodeficiency Virus/adverse effects/genetics/immunology